newsEvinacumab shows promise in severe hypertriglyceridemia trial17 May 2021 | By Hannah Balfour (European Pharmaceutical Review)The investigational antibody evinacumab was able to lower triglycerides by up to 82 percent in severe hypertriglyceridemia patients with acute pancreatitis.
newsHighlights of the EMA’s human medicine committee meeting, April 202126 April 2021 | By Hannah Balfour (European Pharmaceutical Review)The Committee for Medicinal Products for Human Use (CHMP) recommended eight drugs for approval and nine indication extensions.